Please login to the form below

Not currently logged in
Email:
Password:

antibodies

This page shows the latest antibodies news and features for those working in and with pharma, biotech and healthcare.

Lilly partners with AC Immune on tau drug for Alzheimer’s

Lilly partners with AC Immune on tau drug for Alzheimer’s

orally. AbbVie and partner C2N started a phase 2 programme for their ABBV-8E12 monoclonal antibody last year while, just last week, Eisai and University College London (UCL) said they had ... started preparing for phase 1 testing of their antibody E2814

Latest news

More from news
Approximately 15 fully matching, plus 839 partially matching documents found.

Latest Intelligence

  • Combined immunotherapies – potential and pitfalls Combined immunotherapies – potential and pitfalls

    The recent failed phase 3 trial of a combination of MSD’s monoclonal antibody Keytruda (pembrolizumab) and InCyte Corporation’s epacadostat in metastatic melanoma is a case in point he says. ... This has shaped industry development strategies, said

  • Deal Watch October 2018

    Tusk’s first in class anti-CD25 antibodies are expected to enter clinical trials next year. ... Acquisition. $1B. Tusk Therapeutics /. Roche. Anti-CD25 antibody designed to deplete regulatory T-cells.

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    BeiGene’s drug is potentially differentiated from other PD-1s because of the antibody’s engineered Fc region, which preclinical data suggests could minimise potentially negative interactions with other immune cells.

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    targeting drugs from the likes of Crescendo Biologics and Pfizer, and Celldex’ CD27-targeting antibody varlilumab which is in phase II testing for various solid tumour types. ... Following after the first generation of mainly antibody-based

  • 30 Women Leaders in UK Healthcare 30 Women Leaders in UK Healthcare

    8.  Professor Kerry Chester, Antibody Engineering Group at UCL Cancer Institute. Kerry Chester is one of the UK’s foremost experts in antibody engineering, having over twenty years’ experience in the ... Current projects include developing

More from intelligence
Approximately 1 fully matching, plus 97 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 32 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 17 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GK Strategy

GK is award-winning independent communications agency specialising in delivering impactful strategies for clients across the healthcare market....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics